FDA Device Intelligence
HomeBERKELEY ADVANCED BIOMATERIALS, LLC › OptiFuse BA Moldable Matrix

OptiFuse BA Moldable Matrix

BERKELEY ADVANCED BIOMATERIALS, LLC · Model 7888-1250 · UDI-DI 00816125023905

MQV Prescription
1
510(k) clearances
2,073
Adverse events (45 deaths)
120
Recalls
225
Facilities

Description

OptiFuse BA® Moldable Matrix is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible. The 45S5 glass particles are bioactive. The device is available in the form of granules, strips, and putty. The composition of the granules is 60 wt% HA and 40 wt% TCP. The amount of 45S5 granules in the graft is 20 wt%. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. This apatite layer on the 45S5 granules and hydroxyapatite-tri-calcium phosphate granules provide an osteoconductive scaffold onto which the patient’s new bone will grow. During healing, the graft particulate is absorbed and remodeled into new bone.

Recalls

DateFirmReason
2026-07-02IsoTis OrthoBiologics, Inc.Demineralized bone matrix (DBM) in resorbable mesh indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis, were filled with approx. 4.5 cc
2026-03-25Orthorebirth Co LtdResorbable bone void filler falls outside standard specifications.
2026-03-25Orthorebirth Co LtdResorbable bone void filler falls outside standard specifications.
2026-03-09XTANT Medical Holdings, IncProducts were incorrectly labeled with a 5-year shelf life. The approved and validated shelf life is four years.
2025-09-02Berkeley Advanced Biomaterials, LLCDue to incorrect product label (Incorrect product name identified on outer packaging).
2025-04-07SCIENCE & BIO MATERIALSVials of implant bone granules may contain less product then specified on labeling.
2024-11-27IsoTis OrthoBiologics, Inc.Hydration issue resulting in the product being less cohesive and moldable than intended due to an issue with the polymer.
2024-11-27IsoTis OrthoBiologics, Inc.Incorrect expiration date listed on the outer box, which does not align with the correct expiration date listed on the inner tray.
2023-12-22Musculoskeletal Transplant Foundation, Inc.Filling process qualification did not demonstrate adequate process capability. Possible consequences include extended surgery time due to extrudability issues.
2023-12-22Musculoskeletal Transplant Foundation, Inc.Filling process qualification did not demonstrate adequate process capability. Possible consequences include extended surgery time due to extrudability issues.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.